IMMURON Profit Margin 2018-2021 | IMRN
Current and historical gross margin, operating margin and net profit margin for IMMURON (IMRN) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. IMMURON net profit margin as of June 30, 2021 is 0%.
|IMMURON Annual Profit Margins
|IMMURON Quarterly Profit Margins
||Medical - Biomedical and Genetics
Immuron Limited is a bio pharmaceutical Microbiome company. It focused on oral immunotherapy using polyclonal antibody products for humans. The company is involved in developing therapeutic products in NASH, ASH and other diseases mediated through gut disbiosis. Immuron Limited is based in Armadale, Australia.